Case Study

Recordati establishes a PGIM Private Shelf Facility

Headquartered out of Milan, Italy, Recordati Industria Chimica e Farmaceutica S.p.A. manufactures and markets prescription drugs, drugs for rare diseases, and pharmaceutical chemicals for 150+ countries globally. The Company has been listed on the Italian stock exchange since 1984.

Recordati

At a Glance

In 2025, Recordati's management reached out expressing a desire to finance future growth and strengthen our existing relationship. In September of that same year, PGIM provided the Company with a $220million Revolving PGIM Private Shelf Facility to both support near-term investments and be allocated towards capex and future acquisitions.

Recordati's management was impressed by our ability to issue long-term US Private Placements, our flexible and pragmatic approach, and our ability to serve as an institutional long-term investor.

We value the relationship we have built with Recordati over the years, and we look forward to continuing our support for their future growth.

 
Transaction details:
  • $220,000,000 PGIM Private Shelf Facility

Additional Case Studies